文献速递传染病防控与疫情报告慢病防控与筛查卫生政策与健康促进

使用电子烟或雾化产品成人中电子烟或雾化产品使用相关肺损伤(EVALI)的危险因素——伊利诺伊州,2019年7月至10月

Risk Factors for E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products - Illinois, July-October 2019.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2019-11-15

美国暴发电子烟或雾化产品使用相关肺损伤(EVALI)疫情,伊利诺伊州公共卫生部于2019年9月至10月开展在线公众调查,并与66例18-44岁EVALI患者比较。结果显示EVALI患者更可能独家使用含四氢大麻酚(THC)产品、频繁使用(每日超过5次)及从非正规渠道获取,使用Dank Vapes的比值也更高。

要点

  • EVALI患者独家使用含THC产品的调整比值比为2.0(95%CI=1.1-3.6)。
  • EVALI患者频繁使用(每日超过5次)含THC产品的调整比值比为3.1(95%CI=1.6-6.0)。
  • EVALI患者从非正规渠道获取含THC产品的调整比值比为9.2(95%CI=2.2-39.4)。

核心结论

  • 研究结果强化了当前不建议使用含THC的电子烟或雾化产品及不从非正规渠道获取任何电子烟或雾化产品的建议。
  • 由于导致肺损伤的具体化合物或成分尚不清楚,CDC继续建议在疫情调查期间考虑避免使用所有电子烟或雾化产品。

研究设计与样本

  • 伊利诺伊州公共卫生部于2019年9月至10月开展针对伊利诺伊州电子烟或雾化产品使用者的在线公众调查,共4631名调查受访者。
  • 将疫情调查中访谈的66例18-44岁EVALI患者与519名报告使用含THC电子烟或雾化产品的18-44岁调查受访者子集进行比较。

主要发现

  • 4631名调查受访者中,94%报告过去3个月使用任何含尼古丁的电子烟或雾化产品,21%使用任何含THC产品,11%同时使用含THC产品和含尼古丁产品。
  • 含THC产品使用率在18-24岁调查受访者中最高(36%),并随年龄增加而下降。
  • 与519名调查受访者子集相比,EVALI患者报告独家使用含THC产品的调整比值比为2.0(95%CI=1.1-3.6)。
  • EVALI患者频繁使用(每日超过5次)含THC产品的调整比值比为3.1(95%CI=1.6-6.0),从非正规渠道(如经销商、街头或朋友)获取这些产品的调整比值比为9.2(95%CI=2.2-39.4)。
  • EVALI患者使用Dank Vapes(一类主要为假冒的含THC产品)的调整比值比为8.5(95%CI=3.8-19.0)。

关键数值与推荐

  • 独家使用含THC产品:EVALI患者与调查受访者子集相比,aOR=2.0(95%CI=1.1-3.6)。
  • 频繁使用(每日超过5次)含THC产品:aOR=3.1(95%CI=1.6-6.0)。
  • 从非正规渠道获取含THC产品:aOR=9.2(95%CI=2.2-39.4)。
  • 使用Dank Vapes:aOR=8.5(95%CI=3.8-19.0)。

临床怎么用

  • 研究结果强化了当前不建议使用含THC的电子烟或雾化产品及不从非正规渠道获取任何电子烟或雾化产品的建议。
  • CDC继续建议在疫情调查期间考虑避免使用所有电子烟或雾化产品,因导致肺损伤的具体化合物或成分尚不清楚。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The United States is experiencing an unprecedented outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). All EVALI patients have used e-cigarette, or vaping, products, and most (≥85%) have reported using products containing tetrahydrocannabinol (THC) (2,3), the principal psychoactive component of cannabis. To examine whether e-cigarette, or vaping, product use behaviors differed between adult EVALI patients and adults who use these products but have not developed lung injury, the Illinois Department of Public Health (IDPH) conducted an online public survey during September-October 2019 targeting e-cigarette, or vaping, product users in Illinois. Among 4,631 survey respondents, 94% reported using any nicotine-containing e-cigarette, or vaping, products in the past 3 months; 21% used any THC-containing products; and 11% used both THC-containing products and nicotine-containing products. Prevalence of THC-containing product use was highest among survey respondents aged 18-24 years (36%) and decreased with increasing age. E-cigarette, or vaping, product use behaviors of 66 EVALI patients aged 18-44 years who were interviewed as part of the ongoing outbreak investigation were compared with a subset of 519 survey respondents aged 18-44 years who reported use of THC-containing e-cigarette, or vaping, products. Compared with these survey respondents, EVALI patients had higher odds of reporting exclusive use of THC-containing products (adjusted odds ratio [aOR] = 2.0, 95% confidence interval [CI] = 1.1-3.6); frequent use (more than five times per day) of these products (aOR = 3.1, 95% CI = 1.6-6.0), and obtaining these products from informal sources, such as a dealer, off the street, or from a friend (aOR = 9.2, 95% CI = 2.2-39.4). The odds of using Dank Vapes, a class of largely counterfeit THC-containing products, was also higher among EVALI patients (aOR = 8.5, 95% CI = 3.8-19.0). These findings reinforce current recommendations not to use e-cigarette, or vaping, products that contain THC and not to use any e-cigarette, or vaping, products obtained from informal sources. In addition, because the specific compound or ingredient causing lung injury is not yet known, CDC continues to recommend that persons consider refraining from use of all e-cigarette, or vaping, products while the outbreak investigation continues (1).

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Navon L, Jones CM, Ghinai I, et al. Risk Factors for E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products - Illinois, July-October 2019. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31725708. doi:10.15585/mmwr.mm6845e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。